Cite
HARVARD Citation
Mysler, E. et al. (n.d.). Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III Study1. Arthritis and rheumatism. 65 (9), pp. 2368-2379. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mysler, E. et al. (n.d.). Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III Study1. Arthritis and rheumatism. 65 (9), pp. 2368-2379. [Online].